Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats

Melissa A. Linden, Justin A. Fletcher, E. Matthew Morris, Grace M. Meers, Monica L. Kearney, Jacqueline M. Crissey, M. Harold Laughlin, Frank W. Booth, James R. Sowers, Jamal A. Ibdah, John P. Thyfault, R. Scott Rector

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Here, we sought to compare the efficacy of combining exercise and metformin for the treatment of type 2 diabetes and nonalcoholic fatty liver disease (NAFLD) in hyperphagic, obese, type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. OLETF rats (age: 20 wk, hyperglycemic and hyperinsulinemic; n = 10/group) were randomly assigned to sedentary (O-SED), SED plus metformin (O-SED + M; 300 mg·kg-1·day-1), moderate-intensity exercise training (O-EndEx; 20 m/min, 60 min/day, 5 days/wk treadmill running), or O-EndEx + M groups for 12 wk. Long-Evans Tokushima Otsuka (L-SED) rats served as nonhyperphagic controls. O-SED + M, O-EndEx, and O-EndEx + M were effective in the management of type 2 diabetes, and all three treatments lowered hepatic steatosis and serum markers of liver injury; however, O-EndEx lowered liver triglyceride content and fasting hyperglycemia more than O-SED + M. In addition, exercise elicited greater improvements compared with metformin alone on postchallenge glycemic control, liver diacylglycerol content, hepatic mitochondrial palmitate oxidation, citrate synthase, and β-HAD activities and in the attenuation of markers of hepatic fatty acid uptake and de novo fatty acid synthesis. Surprisingly, combining metformin and aerobic exercise training offered little added benefit to these outcomes, and in fact, metformin actually blunted exercise-induced increases in complete mitochondrial palmitate oxidation and β-HAD activity. In conclusion, aerobic exercise training was more effective than metformin administration in the management of type 2 diabetes and NAFLD outcomes in obese hyperphagic OLETF rats. Combining therapies offered little additional benefit beyond exercise alone, and findings suggest that metformin potentially impairs exercise-induced hepatic mitochondrial adaptations.

Original languageEnglish (US)
Pages (from-to)E300-E310
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume306
Issue number3
DOIs
StatePublished - Feb 1 2014
Externally publishedYes

Fingerprint

Inbred OLETF Rats
Metformin
Type 2 Diabetes Mellitus
Exercise
Liver
Palmitates
Fatty Acids
Citrate (si)-Synthase
Diglycerides
Non-alcoholic Fatty Liver Disease
Running
Hyperglycemia
Fasting
Triglycerides
Biomarkers
Wounds and Injuries

Keywords

  • De novo lipogenesis
  • Exercise training
  • Hepatic mitochondria
  • Metformin
  • Nonalcoholic fatty liver disease
  • Otsuka Long-Evans Tokushima Fatty rats

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)

Cite this

Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats. / Linden, Melissa A.; Fletcher, Justin A.; Matthew Morris, E.; Meers, Grace M.; Kearney, Monica L.; Crissey, Jacqueline M.; Harold Laughlin, M.; Booth, Frank W.; Sowers, James R.; Ibdah, Jamal A.; Thyfault, John P.; Scott Rector, R.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 306, No. 3, 01.02.2014, p. E300-E310.

Research output: Contribution to journalArticle

Linden, MA, Fletcher, JA, Matthew Morris, E, Meers, GM, Kearney, ML, Crissey, JM, Harold Laughlin, M, Booth, FW, Sowers, JR, Ibdah, JA, Thyfault, JP & Scott Rector, R 2014, 'Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats', American Journal of Physiology - Endocrinology and Metabolism, vol. 306, no. 3, pp. E300-E310. https://doi.org/10.1152/ajpendo.00427.2013
Linden, Melissa A. ; Fletcher, Justin A. ; Matthew Morris, E. ; Meers, Grace M. ; Kearney, Monica L. ; Crissey, Jacqueline M. ; Harold Laughlin, M. ; Booth, Frank W. ; Sowers, James R. ; Ibdah, Jamal A. ; Thyfault, John P. ; Scott Rector, R. / Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats. In: American Journal of Physiology - Endocrinology and Metabolism. 2014 ; Vol. 306, No. 3. pp. E300-E310.
@article{cd2e9493e1d84dbd8807542a74b0df0c,
title = "Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats",
abstract = "Here, we sought to compare the efficacy of combining exercise and metformin for the treatment of type 2 diabetes and nonalcoholic fatty liver disease (NAFLD) in hyperphagic, obese, type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. OLETF rats (age: 20 wk, hyperglycemic and hyperinsulinemic; n = 10/group) were randomly assigned to sedentary (O-SED), SED plus metformin (O-SED + M; 300 mg·kg-1·day-1), moderate-intensity exercise training (O-EndEx; 20 m/min, 60 min/day, 5 days/wk treadmill running), or O-EndEx + M groups for 12 wk. Long-Evans Tokushima Otsuka (L-SED) rats served as nonhyperphagic controls. O-SED + M, O-EndEx, and O-EndEx + M were effective in the management of type 2 diabetes, and all three treatments lowered hepatic steatosis and serum markers of liver injury; however, O-EndEx lowered liver triglyceride content and fasting hyperglycemia more than O-SED + M. In addition, exercise elicited greater improvements compared with metformin alone on postchallenge glycemic control, liver diacylglycerol content, hepatic mitochondrial palmitate oxidation, citrate synthase, and β-HAD activities and in the attenuation of markers of hepatic fatty acid uptake and de novo fatty acid synthesis. Surprisingly, combining metformin and aerobic exercise training offered little added benefit to these outcomes, and in fact, metformin actually blunted exercise-induced increases in complete mitochondrial palmitate oxidation and β-HAD activity. In conclusion, aerobic exercise training was more effective than metformin administration in the management of type 2 diabetes and NAFLD outcomes in obese hyperphagic OLETF rats. Combining therapies offered little additional benefit beyond exercise alone, and findings suggest that metformin potentially impairs exercise-induced hepatic mitochondrial adaptations.",
keywords = "De novo lipogenesis, Exercise training, Hepatic mitochondria, Metformin, Nonalcoholic fatty liver disease, Otsuka Long-Evans Tokushima Fatty rats",
author = "Linden, {Melissa A.} and Fletcher, {Justin A.} and {Matthew Morris}, E. and Meers, {Grace M.} and Kearney, {Monica L.} and Crissey, {Jacqueline M.} and {Harold Laughlin}, M. and Booth, {Frank W.} and Sowers, {James R.} and Ibdah, {Jamal A.} and Thyfault, {John P.} and {Scott Rector}, R.",
year = "2014",
month = "2",
day = "1",
doi = "10.1152/ajpendo.00427.2013",
language = "English (US)",
volume = "306",
pages = "E300--E310",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats

AU - Linden, Melissa A.

AU - Fletcher, Justin A.

AU - Matthew Morris, E.

AU - Meers, Grace M.

AU - Kearney, Monica L.

AU - Crissey, Jacqueline M.

AU - Harold Laughlin, M.

AU - Booth, Frank W.

AU - Sowers, James R.

AU - Ibdah, Jamal A.

AU - Thyfault, John P.

AU - Scott Rector, R.

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Here, we sought to compare the efficacy of combining exercise and metformin for the treatment of type 2 diabetes and nonalcoholic fatty liver disease (NAFLD) in hyperphagic, obese, type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. OLETF rats (age: 20 wk, hyperglycemic and hyperinsulinemic; n = 10/group) were randomly assigned to sedentary (O-SED), SED plus metformin (O-SED + M; 300 mg·kg-1·day-1), moderate-intensity exercise training (O-EndEx; 20 m/min, 60 min/day, 5 days/wk treadmill running), or O-EndEx + M groups for 12 wk. Long-Evans Tokushima Otsuka (L-SED) rats served as nonhyperphagic controls. O-SED + M, O-EndEx, and O-EndEx + M were effective in the management of type 2 diabetes, and all three treatments lowered hepatic steatosis and serum markers of liver injury; however, O-EndEx lowered liver triglyceride content and fasting hyperglycemia more than O-SED + M. In addition, exercise elicited greater improvements compared with metformin alone on postchallenge glycemic control, liver diacylglycerol content, hepatic mitochondrial palmitate oxidation, citrate synthase, and β-HAD activities and in the attenuation of markers of hepatic fatty acid uptake and de novo fatty acid synthesis. Surprisingly, combining metformin and aerobic exercise training offered little added benefit to these outcomes, and in fact, metformin actually blunted exercise-induced increases in complete mitochondrial palmitate oxidation and β-HAD activity. In conclusion, aerobic exercise training was more effective than metformin administration in the management of type 2 diabetes and NAFLD outcomes in obese hyperphagic OLETF rats. Combining therapies offered little additional benefit beyond exercise alone, and findings suggest that metformin potentially impairs exercise-induced hepatic mitochondrial adaptations.

AB - Here, we sought to compare the efficacy of combining exercise and metformin for the treatment of type 2 diabetes and nonalcoholic fatty liver disease (NAFLD) in hyperphagic, obese, type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. OLETF rats (age: 20 wk, hyperglycemic and hyperinsulinemic; n = 10/group) were randomly assigned to sedentary (O-SED), SED plus metformin (O-SED + M; 300 mg·kg-1·day-1), moderate-intensity exercise training (O-EndEx; 20 m/min, 60 min/day, 5 days/wk treadmill running), or O-EndEx + M groups for 12 wk. Long-Evans Tokushima Otsuka (L-SED) rats served as nonhyperphagic controls. O-SED + M, O-EndEx, and O-EndEx + M were effective in the management of type 2 diabetes, and all three treatments lowered hepatic steatosis and serum markers of liver injury; however, O-EndEx lowered liver triglyceride content and fasting hyperglycemia more than O-SED + M. In addition, exercise elicited greater improvements compared with metformin alone on postchallenge glycemic control, liver diacylglycerol content, hepatic mitochondrial palmitate oxidation, citrate synthase, and β-HAD activities and in the attenuation of markers of hepatic fatty acid uptake and de novo fatty acid synthesis. Surprisingly, combining metformin and aerobic exercise training offered little added benefit to these outcomes, and in fact, metformin actually blunted exercise-induced increases in complete mitochondrial palmitate oxidation and β-HAD activity. In conclusion, aerobic exercise training was more effective than metformin administration in the management of type 2 diabetes and NAFLD outcomes in obese hyperphagic OLETF rats. Combining therapies offered little additional benefit beyond exercise alone, and findings suggest that metformin potentially impairs exercise-induced hepatic mitochondrial adaptations.

KW - De novo lipogenesis

KW - Exercise training

KW - Hepatic mitochondria

KW - Metformin

KW - Nonalcoholic fatty liver disease

KW - Otsuka Long-Evans Tokushima Fatty rats

UR - http://www.scopus.com/inward/record.url?scp=84893388150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893388150&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00427.2013

DO - 10.1152/ajpendo.00427.2013

M3 - Article

C2 - 24326426

AN - SCOPUS:84893388150

VL - 306

SP - E300-E310

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 3

ER -